SFA Therapeutics Harnesses Power Of Bacterial Metabolites To Treat Inflammatory Disease

Emerging Company Profile: SFA Therapeutics
SFA001 Prevented Progression To Liver Cancer In A Mouse Model • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Emerging Company Profiles

More from Start-Ups & SMEs